Back to 
Invesco Ltd.
Invesco Ltd.
TVRD
2 quarters
Position history for Invesco Ltd.'s holdings in Tvardi Therapeutics, Inc.
No. Invesco exited its TVRD (Tvardi Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 82,614 shares worth $3.2M. Invesco first reported TVRD in Q3 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$3.2M
Total Shares Change
-82,614
Quarter-by-Quarter History
Other major holders of TVRD: Vanguard Group Inc., BlackRock, Inc., Geode Capital Management, LLC